Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 94 Neoplasm Metastasis 9 Prostatic Neoplasms, Castration-Resistant 5 Breast Neoplasms 3 Neoplasms 2 Metastatic Castration Resistant Prostate Cancer 2 Castration-resistant Prostate Cancer 2 Urinary Bladder Neoplasms 1 Stage II Prostate Adenocarcinoma 1 Salivary Glands Tumors 1 Rate of PSA Response in Oligometastatic,CRPC Undergoing SBRT in Combination With Abiraterone Acetate (AA), Compared to Patients Treated With AA Alone 1 Prostate Cancer Metastatic 1 Prostate Adenocarcinoma 1 Pharmacogenetic Study 1 Oligometastatic Prostate Carcinoma 1 Neoadjuvant Therapy 1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1 Metastatic Hormone Refractory Prostate Cancer 1 Metastatic Castration-resistent Prostate Cancer 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer 1 Dementia 1 Cushing Syndrome 1 Cognitive Dysfunction 1 Castrate-resistant Prostate Cancer 1 Carcinoma, Transitional Cell 1 Cancer Pain 1 Adrenocortical Carcinoma 1 Adenocarcinoma 1

Interventions

Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pharmacogenetic Study × Abiraterone Acetate × Clear all

NCT01858441 2020-12-04

ABIGENE

Centre Antoine Lacassagne

Phase NA Completed

Pharmacogenetic Study

Data powered by HemOnc (CC BY 4.0) Colophon ⚡